Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Jan;47(1):183–190.

Dual action of leucocyte dialysates and of thymosin on the recovery of sheep-cell-rosetting capacity in trypsinized human lymphocytes.

I L Sargent, M R Salaman, H Valdimarsson
PMCID: PMC1536376  PMID: 7094423

Abstract

Trypsinization of human blood lymphocytes abolishes their capacity to form rosettes with sheep erythrocytes (E-rosettes) and this is regained in part on incubation of the cells at 37 degrees C for 3 hr. The recovery of rosetting capacity was found to be accelerated in the presence of dialysable extracts of human leucocytes (DLE) or bovine thymosin fraction 5 (THFV). For both DLE and THFV two types of effect were demonstrated. At lower concentrations the stimulation of recovery was dependent on the presence of the agent during incubation and it presumably comes about through an effect on the metabolic process required for regeneration of the E-receptors. At higher concentrations another mechanism is apparent since the agents were now effective when added after incubation. This last phenomenon is wholly dependent on prior incubation of the trypsinized lymphocytes in medium alone and it probably involves attachment of components of DLE and THFV to incompletely recovered cells, thereby providing a more favourable charge environment for E-rosette formation. A similar process of adhesion-promotion may be occurring in certain in-vitro tests with THFV which are carried out on lymphocytes from immunodeficient patients. On the other hand, it is the other mechanism, that of metabolic action, which is likely to be the predominant consideration in relation to treatment of such patients with DLE or THFV.

Full text

PDF
183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed A., Wong D. M., Thurman G. B., Low T. L., Goldstein A. L., Sharkis S. J., Goldschneider I. T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides. Ann N Y Acad Sci. 1979;332:81–94. doi: 10.1111/j.1749-6632.1979.tb47100.x. [DOI] [PubMed] [Google Scholar]
  2. Brostoff J. A simple technique for counting rosettes using acridine orange. J Immunol Methods. 1974 Aug;5(3):303–303. doi: 10.1016/0022-1759(74)90115-x. [DOI] [PubMed] [Google Scholar]
  3. Holzman R. S., Lawrence H. S. In vitro augmentation of lymphocyte sheep cell rosette formation by leukocyte dialysates. J Immunol. 1977 May;118(5):1672–1676. [PubMed] [Google Scholar]
  4. Horowitz S. D., Goldstein A. L. The in vitro induction of differentiation of putative human stem cells by thymosin and agents that affect cyclic AMP. Clin Immunol Immunopathol. 1978 Apr;9(4):408–418. doi: 10.1016/0090-1229(78)90137-x. [DOI] [PubMed] [Google Scholar]
  5. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Khan A., Garrison O., Hill J. M., Antonetti A., Hill N. O., Gracy R. W. Isolation and characterization of immunopeptide from dialyzable leukocyte extract. Cell Immunol. 1980 Oct;55(2):420–427. doi: 10.1016/0008-8749(80)90172-0. [DOI] [PubMed] [Google Scholar]
  7. Khan A., Thometz D., Garrison O., Hill J. M. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF. Ann Allergy. 1976 May;36(5):330–336. [PubMed] [Google Scholar]
  8. Kirkpatrick C. H. Properties and activities of transfer factor. J Allergy Clin Immunol. 1975 Jun;55(6):411–421. doi: 10.1016/0091-6749(75)90080-9. [DOI] [PubMed] [Google Scholar]
  9. Low T. L., Thurman G. B., Chincarini C., McClure J. E., Marshall G. D., Hu S. K., Goldstein A. L. Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation. Ann N Y Acad Sci. 1979;332:33–48. doi: 10.1111/j.1749-6632.1979.tb47095.x. [DOI] [PubMed] [Google Scholar]
  10. Mendes N. F., Saraiva P. J., Santos O. B. Restorative effect of normal human serum, transfer factor and thymosin on the ability of heated human lymphocytes to form rosettes with sheep erythrocytes. Cell Immunol. 1975 Jun;17(2):560–566. doi: 10.1016/s0008-8749(75)80060-8. [DOI] [PubMed] [Google Scholar]
  11. Naylor P. H., Sheppard H., Thurman G. B., Goldstein A. L. Increase of cyclic GMP induced in murine thymocytes by thymosin fraction 5. Biochem Biophys Res Commun. 1976 Dec 20;73(4):843–849. doi: 10.1016/0006-291x(76)90198-4. [DOI] [PubMed] [Google Scholar]
  12. Pang G. T., Wiggins P. M., Wilson J. D. Nature of the union between sheep red blood cells and T lymphocytes. Int Arch Allergy Appl Immunol. 1976;51(6):751–756. doi: 10.1159/000231653. [DOI] [PubMed] [Google Scholar]
  13. Salaman M. R. An investigation into the antigen-specificity of transfer factor in its stimulatory action on lymphocyte transformation. Immunology. 1978 Aug;35(2):247–256. [PMC free article] [PubMed] [Google Scholar]
  14. Spitler L. E. Transfer factor in immunodeficiency diseases. Ann N Y Acad Sci. 1979;332:228–235. doi: 10.1111/j.1749-6632.1979.tb47116.x. [DOI] [PubMed] [Google Scholar]
  15. Valdimarsson H., Hambleton G., Henry K., McConnell I. Restoration of T-lymphocyte deficiency with dialysable leucocyte extract. Clin Exp Immunol. 1974 Feb;16(2):141–152. [PMC free article] [PubMed] [Google Scholar]
  16. Valdimarsson H., McGuire R. L. Crude transfer-factor preparations stimulate trypsinized human lymphocytes to form rosettes with sheep red cells. Clin Exp Immunol. 1977 Aug;29(2):261–265. [PMC free article] [PubMed] [Google Scholar]
  17. Vassef A. A., Flora J. B., Weeks J. G., Bibbs B. S., Schmidt R. R. The effects of enzyme synthesis and stability and of deoxyribonucleic acid replication on the cellular levels of aspartate transcarbamylase during the cell cycle of eucaryote Chlorella. J Biol Chem. 1973 Mar 25;248(6):1976–1985. [PubMed] [Google Scholar]
  18. Wara D. W., Ammann A. J. Thymosin treatment of children with primary immunodeficiency disease. Transplant Proc. 1978 Mar;10(1):203–209. [PubMed] [Google Scholar]
  19. Wybran J., Levin A. S., Spitler L. E., Fudenberg H. H. Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med. 1973 Apr 5;288(14):710–713. doi: 10.1056/NEJM197304052881405. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES